SEC Form D private-offering filing

LEXICON PHARMACEUTICALS, INC.

Name: LEXICON PHARMACEUTICALS, INC. - new SEC Form D private-offering filing, The Woodlands, TX
Published: 2026-02-17

A new SEC Form D private-offering notice from The Woodlands, TX, a $59,150,000 filer-stated offering target in Biotech. The source filing is one click away.

LEXICON PHARMACEUTICALS, INC. site↗ Verified via SEC Form D

Lexicon Pharmaceuticals is a publicly traded biopharmaceutical company (Nasdaq: LXRX) developing treatments for cardiometabolic disease and chronic pain, including the approved heart failure drug INPEFA.

Filed 2026-02-17Filed to raise $59,150,000First money in 2026-02-02Raised so far $55,668,255HQ (as filed) The Woodlands, TXSector Biotech ✓Stage (inferred) GrowthCall status Needs classification

Source linked the Form D on EDGAR↗Website verified lexpharma.com↗Named in the filing 16 executives & directors

Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.